Real-world Insight Into Systemic Therapies for HCC: Single-center Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza raka wątroby (HCC)
- •Funkcja wątroby klasa Child-Pugh A lub B7
- •Ogólny stan zdrowia 0-1 w skali ECOG
- •Zaawansowana postać nowotworu wątroby (stadium BCLC C) lub stadium B z rozległym zajęciem lub progresją po poprzednim leczeniu
✗ Disqualifies
- •Inne nowotwory niż rak wątroby
- •Funkcja wątroby klasa Child-Pugh B (8-9 pkt) lub C
- •Kwalifikacja do innych metod leczenia niż terapia systemowa
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 10, 2026
- Sex
- No restrictions
Locations (1)
Mansoura University Hospitals
Al Mansurah, Egypt
Trial contact
Mahmoud M El-Bendary, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.